Introduction
Disseminated gonococcal infection is a rare but important complication of mucosal infection with Neisseria gonorrhoeae.' l Most strains recovered from systemic disease require arginine, hypoxanthine, and uracil for growth,23 and show pronounced sensitivity to penicillin. 4 We report, however, on a patient with disseminated gonococcal infection whose gonococcal isolate was atypical and whose complement pathway was defective.
Patient and methods
A West Indian girl aged 17, who was constitutionally well, presented on the first day of her menses with asymmetric oliogoarthropathy and tenosynovitis of four day's duration. She had developed the nephrotic syndrome four years earlier, had required haemodialysis after two years, and was currently receiving azathioprine 150 mg and prednisolone 17-5 mg a day three months after undergoing cadaveric renal transplant, the underlying pathology being mesangial proliferation.
N gonorrhoeae was isolated from a high vaginal swab. Cultures for gonococci from the urethra, throat, and blood gave negative results.
She was treated with high doses ofpenicillin for nine days; benzyl penicillin 600 mg intravenously four times a day for 48 hours followed by a week's course of amoxycillin 500 mg orally three times a day. Her symptoms resolved within two days. Follow up gonococcal cultures were reported as giving negative results on two occasions.
Her male sexual partner and his two additional female sexual contacts were culture positive for N gonorrhoeae; none had evidence of disseminated gonococcal infection. MICROBIOLOGY N gonorrhoeae was isolated on neisserial medium containing 36 g/l GC base agar (Difco), 1% IsoVitalex (BBL), and vancomycin, colistin, trimethoprim, and amphotericin incubated at 36°C for 48 hours in 6% carbon dioxide. Colonies of oxidase positive Gram negative cocci were confirmed as being Ngonorrhoeae by their ability to produce acid from glucose, but not from maltose or sucrose, and their inability to produce p galactosidase.
Auxotyping was performed by the method described by Catlin et al.5 Susceptibility to penicillin was assessed by incorporating penicillin (range 0x01 5 mg/l to 2 mg/l) into agar plates by methods previously described. 6 The serogroup and serovar were identified by a coagglutination test using a panel of monoclonal antibodies7 raised to the outer membrane protein (PI), which were provided by Dr S Bygdeman, Stockholm, Sweden. The presence of serum IgG and IgA antibodies to a cell envelope extract ofNgonorrhoeae was verified using an enzyme linked assay.8 169 The role of opsonisation in mucosal and disseminated gonococcal infection is not defined. A reduced Saccharomyces opsonin index has been associated with various pyogenic infections ,especially in childhood, but not with disseminated gonococcal infection .
The abnormal handling of N gonorrhoeae in this patient may also have been due to the defect in opsonisation, though disseminated gonococcal infec- 14 Alternative pathway complement activation may be necessary to initiate the lytic pathway as part of non-specific defence against the gonococcus, pending a specific antibody response that would utilise classic pathway activation as a means of promoting lytic pathway activation.
Since presenting this case report, a second patient with disseminated gonococcal infection has been found to have a reduced Saccharomyces opsonin index, and an associated defect of Candida opsonisation (Lacey C, personal communication). This additional case lends further support to the idea that this type of complement pathway defect is indeed an important background to disseminated gonococcal infection. It also seems unlikely that the immunosuppressive treatment given to our patient was a major factor in predisposing to disseminated gonococcal infection.
In conclusion, disseminated gonococcal infection was caused by an atypical strain ofNgonorrhoeae in a patient who had a defect of the complement pathway not previously associated with disseminated gonococcal infection.
